Concepedia

Author

Joan Cid

Hospital Clínic de BarcelonaORCID

Also Known As

J CID, J Cid, J. Cid, J. Cid, M. PanadÉs, Jesús Ignacio Mazadiego Cid, Joan Cid, Paola Charry

378

Publications

6.3K

Citations

41

H-Index

103

Concepts

All Affiliations

Hospital Clínic de BarcelonaConsorci Institut D'Investigacions Biomediques August Pi I SunyerUniversitat de BarcelonaBanc de Sang i TeixitsJosep Carreras Leukaemia Research Institute
JC

About

Joan Cid is an author at Hospital Clínic de Barcelona specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

24

521

2

Engineering

7

7

275

3

Health Sciences

1

1

16

4

Public Health

1

1

37

5

Biochemistry

1

1

18

Joan Cid

×

96

Publications

3.5K

Citations

32

H-Index

YearCitations

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial

Irati Zubizarreta, Georgina Flórez‐Grau, Gemma Vila,

Proceedings of the National Academy of Sciences

2019

175

Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn’s Disease: A Phase I Study

Aranzazu Jauregui-Amezaga, Raquel Cabezón, Anna Ramírez‐Morros,

Journal of Crohn s and Colitis

2015

156

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

Valentín Ortiz‐Maldonado, Susana Rives, María Castellà,

Molecular Therapy

2020

151

Influence of the nitriding time in the wear behaviour of an AISI H13 steel during a crankshaft forging process

G.A. Rodríguez-Castro, A. Fernández–Vicente, Joan Cid

Wear

2007

135

Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial

María Castellà, Miguel Caballero‐Baños, Valentín Ortiz‐Maldonado,

Frontiers in Immunology

2020

132

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions

María Castellà, Anna Boronat, Raquel Martín‐Ibáñez,

Molecular Therapy — Methods & Clinical Development

2018

122

A multi‐centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

Miquel Lozano, Folke Knutson, R. Tardivel,

British Journal of Haematology

2011

112

Effectiveness and safety of tranexamic acid administration during total knee arthroplasty

Miquel Lozano, M. Basora, L. Peidró,

Vox Sanguinis

2008

100

Low frequency of anti‐D alloimmunization following D+ platelet transfusion: the Anti‐D Alloimmunization after D‐incompatible Platelet Transfusions (ADAPT) study

Joan Cid, Miquel Lozano, Alyssa Ziman,

British Journal of Haematology

2014

84

Complement Activation and Thrombotic Microangiopathies

Marta Palomo, Miquel Blasco, Patricia Molina,

Clinical Journal of the American Society of Nephrology

2019

80

Page 1